Neuroinflammation in Parkinson’s Disease Animal Models: A Cell Stress Response or a Step in Neurodegeneration?
The DOI matches its Crossref record; 280 of the 282 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The motor symptoms of Parkinson's disease are due to the progressive degeneration of dopaminergic neurons in the substantia nigra. Multiple neuroinflammatory processes are exacerbated in Parkinson's disease, including glial-mediated reactions, increased expression of proinflammatory substances, and lymphocytic infiltration, particularly in the substantia nigra. Neuroinflammation is also implicated in the neurodegeneration and consequent behavioral symptoms of many Parkinson's disease animal models, although it is not clear whether these features emulate pathogenic steps in the genuine disorder or if some inflammatory features provide protective stress responses. Here, we compare and summarize findings on neuroinflammatory responses and effects on behavior in a wide range of toxin-based, inflammatory and genetic Parkinson's disease animal models.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“α-Synuclein modified by ONOO− or oxidized dopamine forms aggregates and Lewy bodies (214) that further activate microglia (211).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [214]
Citations
Cites
2 retracted
Items 201–281 of 281
α-Synuclein transgenic mice exhibit reduced anxiety-like behaviour
George, S., van den Buuse, M., Mok, S. S., Masters, C. L., Li, Q., & Culvenor, J. G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.017 · Cited by 94
Mitra, S., Chakrabarti, N., & Bhattacharyya, A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-163 · Cited by 91
Gombash, S. E., Manfredsson, F. P., Kemp, C. J., Kuhn, N. C., Fleming, S. M., Egan, A. E., Grant, L. M., Ciucci, M. R., MacKeigan, J. P., & Sortwell, C. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081426 · Cited by 91
Hernández‐Romero, M. D. C., Argüelles, S., Villarán, R. F., De Pablos, R. M., Delgado‐Cortés, M. J., Santiago, M., Herrera, A. J., Cano, J., & Machado, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05148.x · Cited by 91
Gupta, S. P., Patel, S., Yadav, S., Singh, A. K., Singh, S. K., & Singh, M. P. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0176-5 · Cited by 90
Zhou, F., Wu, J., Sun, X., Yao, H., Ding, J., & Hu, G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301381 · Cited by 88
Corti, O., & Brice, A. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.11.002 · Cited by 85
Yasuda, Y. U., Shimoda, T., Uno, K., Tateishi, N., Furuya, S., Yagi, K., Suzuki, K., & Fujita, S. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.08.003 · Cited by 85
Opening of microglial KATP channels inhibits rotenone‐induced neuroinflammation
Zhou, F., Yao, H., Wu, J., Ding, J., Sun, T., & Hu, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00144.x · Cited by 84
Herva, M. E., Zibaee, S., Fraser, G., Barker, R. A., Goedert, M., & Spillantini, M. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542340 · Cited by 83
Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
Johnston, L. C., Su, X., Maguire‐Zeiss, K. A., Horovitz, K., Ankoudinova, I., Guschin, D. Y., Hadaczek, P., Federoff, H. J., Bankiewicz, K. S., & Forsayeth, J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.113 · Cited by 82
Wilms, H., Rosenstiel, P., Romero-Ramos, M., Arlt, A., Schäfer, H., Seegert, D., Kahle, P. J., Odoy, S., Claasen, J. H., Holzknecht, C., et al. (2009) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200902200405 · Cited by 82
Franzén, B., Duvefelt, K., Jonsson, C., Engelhardt, B., Ottervald, J., Wickman, M., Yang, Y., & Schuppe‐Koistinen, I. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00185-2 · Cited by 78
Sindhu, K. M., Saravanan, K. S., & Mohanakumar, K. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.051 · Cited by 78
Lima, M. D. M. S., Reksidler, A. B., Zanata, S. M., Machado, H. B., Tufik, S., & Vital, M. A. B. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.016 · Cited by 76
Thomas, B., von Coelln, R., Mandir, A. S., Trinkaus, D. B., Farah, M. H., Lim, K., Calingasan, N. Y., Beal, M. F., Dawson, V. L., & Dawson, T. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.021 · Cited by 76
Yadav, S., Gupta, S. P., Srivastava, G., Srivastava, P. K., & Singh, M. P. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0682-0 · Cited by 76
Kopin, I. J. (1987) · Environmental Health Perspectives · doi:10.1289/ehp.877545 · Cited by 76
Wang, Q., Shin, E.-J., Nguyen, X.-K. T., Li, Q., Bach, J.-H., Bing, G., Kim, W.-K., Kim, H.-C., & Hong, J.-S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-124 · Cited by 73
Non-Motor and Motor Features in LRRK2 Transgenic Mice
Bichler, Z., Lim, H. C., Zeng, L., & Tan, E. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070249 · Cited by 72
Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation
Lee, K.-W., Zhao, X., Im, J.-Y., Grosso, H., Jang, W. H., Chan, T. W., Sonsalla, P. K., German, D. C., Ichijo, H., Junn, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029935 · Cited by 71
Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake
Zhou, H., Huang, C., Tong, J., Hong, W. C., Liu, Y., & Xia, X. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.753 · Cited by 71
Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
Riachi, N. J., LaManna, J. C., & Harik, S. I. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23492-9 · Cited by 70
Gao, J. J., Diesl, V., Wittmann, T., Morrison, D. C., Ryan, J. L., Vogel, S. N., & Follettie, M. T. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1234 · Cited by 70
Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates.
Barkholt, P., Sánchez-Guajardo, V., Kirik, D., & Romero-Ramos, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.004 · Cited by 67
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
Perez, F. A., Curtis, W. R., & Palmiter, R. D. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-71 · Cited by 67
In vivo expression of aquaporin‐4 by reactive microglia
Tomás‐Camardiel, M., Venero, J. L., de Pablos, R. M., Rite, I., Machado, A., & Cano, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02759.x · Cited by 66
Mogi, M., Togari, A., Tanaka, K.-I., Ogawa, N., Ichinose, H., & Nagatsu, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01275-1 · Cited by 63
Rotenone and paraquat do not directly activate microglia or induce inflammatory cytokine release
Klintworth, H. M., Garden, G. A., & Xia, Z. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.065 · Cited by 61
Li, Z., Arnaud, L., Rockwell, P., & Figueiredo‐Pereira, M. E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02456.x · Cited by 59
L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Serra, P. A., Impagnatiello, F., Morale, M. C., & Marchetti, B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-83 · Cited by 59
Foix, C., & Nicolesco, J. (1925) · Masson eBooks · Cited by 58
Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson’s Disease
Na, S. J., DiLella, A. G., Lis, E. V., Jones, K., Levine, D. M., Stone, D. J., & Hess, J. F. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0133-3 · Cited by 57
Li, X., Moore, D. J., Xiong, Y., Dawson, T. M., & Dawson, V. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127639 · Cited by 57
Wachter, B., Schürger, S., Rolinger, J., von Ameln-Mayerhofer, A., Berg, D., Wagner, H.-J., & Küppers, E. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1061-x · Cited by 57
Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration
Jung, B.-D., Shin, E., Nguyen, X.-K. T., Jin, C., Bach, J., Park, S. J., Nah, S.-Y., Wie, M., Bing, G., & Kim, H. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.10.005 · Cited by 55
Neuroprotection by Silencing iNOS Expression in a 6-OHDA Model of Parkinson’s Disease
Li, M., Dai, F.-R., Du, X., Yang, Q., & Chen, Y. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9814-5 · Cited by 55
CNS infections, sepsis and risk of Parkinson's disease
Fang, F., Wirdefeldt, K., Jacks, A., Kamel, F., Ye, W., & Chen, H. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys052 · Cited by 54
Differential aggregation properties of alpha-synuclein isoforms
Bungeroth, M., Appenzeller, S., Regulin, A., Völker, W., Lorenzen, I., Grötzinger, J., Pendziwiat, M., & Kuhlenbäumer, G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.009 · Cited by 54
Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Soto, M. S., Delgado‐Cortés, M. J., et al. (2011) · ISRN Neurology · doi:10.5402/2011/476158 · Cited by 54
Selvakumar, G. P., Janakiraman, U., Essa, M. M., Thenmozhi, A. J., & Manivasagam, T. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.010 · Cited by 54
Ambrosi, G., Armentero, M., Levandis, G., Bramanti, P., Nappi, G., & Blandini, F. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.01.011 · Cited by 53
Wang, A., Liou, Y., Pawlak, C. R., & Ho, Y. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.11.006 · Cited by 53
Miller, R. M., Kiser, G. L., Kaysser-Kranich, T., Casaceli, C., Colla, E., Lee, M. K., Palaniappan, C., & Federoff, H. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.005 · Cited by 53
Effects of chronic low dose rotenone treatment on human microglial cells
Shaikh, S. B., & Nicholson, L. F. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-55 · Cited by 51
Sadeghian, M., Marinova-Mutafchieva, L., Broom, L., Davis, J. L., Virley, D. J., Medhurst, A. D., & Dexter, D. T. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.010 · Cited by 49
Sekiyama, K., Sugama, S., Fujita, M., Sekigawa, A., Takamatsu, Y., Waragai, M., Takenouchi, T., & Hashimoto, M. (2012) · Parkinson's Disease · doi:10.1155/2012/271732 · Cited by 48
Armentero, M.-T., Levandis, G., Nappi, G., Bazzini, E., & Blandini, F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.016 · Cited by 47
Geng, Y., Fang, M., Wang, J., Yu, H., Hu, Z., Yew, D. T. W., & Chen, W. (2011) · Phytotherapy Research · doi:10.1002/ptr.3538 · Cited by 47
PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates
Matsui, H., Gavinio, R., Asano, T., Uemura, N., Ito, H., Taniguchi, Y., Kobayashi, Y., Maki, T., Shen, J., Takeda, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt095 · Cited by 47
Dopamine‐dependent neurotoxicity of lipopolysaccharide in substantia nigra
De Pablos, R. M., Herrera, A. J., Villarán, R. F., Cano, J., & Machado, A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2153fje · Cited by 45
Vázquez-Claverie, M., Garrido-Gil, P., San Sebastián, W., Izal-Azcárate, A., Belzunegui, S., Marcilla, I., López, B., & Luquin, M.-R. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181b35e41 · Cited by 44
Nigrostriatal Damage with 6‐OHDA: Validation of Routinely Applied Procedures
FULCERI, F., BIAGIONI, F., LENZI, P., FALLENI, A., GESI, M., RUGGIERI, S., & FORNAI, F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.032 · Cited by 44
Drolet, R. E., Sanders, J. M., & Kern, J. T. (2011) · Journal of Neurogenetics · doi:10.3109/01677063.2011.627072 · Cited by 44
Pierre, S.-R., Lemmens, M. A., & Figueiredo-Pereira, M. E. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-18 · Cited by 43
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist
Klementiev, B., Li, S., Korshunova, I., Dmytriyeva, O., Pankratova, S., Walmod, P. S., Kjær, L. K., Dahllöf, M. S., Lundh, M., Christensen, D. P., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-27 · Cited by 43
Maekawa, T., Mori, S., Sasaki, Y., Miyajima, T., Azuma, S., Ohta, E., & Obata, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-15 · Cited by 41
Bobyn, J., Mangano, E. N., Gandhi, A., Nelson, E., Moloney, K., Clarke, M., & Hayley, S. P. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-86 · Cited by 41
Gupta, A. K., Kumar, A., & Kulkarni, S. K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.01.017 · Cited by 40
Ohnuki, T., Nakamura, A., Okuyama, S., & Nakamura, S. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.066 · Cited by 39
A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34+ cells
Liu, J., Guo, Y., Hirokawa, M., Iwamoto, K., Ubukawa, K., Michishita, Y., Fujishima, N., Tagawa, H., Takahashi, N., Xiao, W., et al. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.12.002 · Cited by 39
L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Impagnatiello, F., & Marchetti, B. (2011) · Rejuvenation Research · doi:10.1089/rej.2010.1134 · Cited by 38
Lee, H. J., Jang, S. H., Kim, H., Yoon, J., & Chung, K. C. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1004-7 · Cited by 37
Kunikowska, G., & Jenner, P. G. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03149-3 · Cited by 35
Increased MMP-3 and CTGF expression during lipopolysaccharide-induced dopaminergic neurodegeneration
McClain, J. A., Phillips, L. L., & Fillmore, H. L. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.05.044 · Cited by 34
PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation
Lee, H. J., & Chung, K. C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-271 · Cited by 34
Natural toxins implicated in the development of Parkinson’s disease
Salama, M., & Arias-Carrión, Ó. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611413004 · Cited by 34
Mulcahy, P. J., O’Doherty, A., Paucard, A., O’Brien, T., Kirik, D., & Dowd, E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.051 · Cited by 33
Hennis, M. R., Marvin, M. A., Taylor, C. M., & Goldberg, M. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.009 · Cited by 32
Gomide, V. C., Bibancos, T., & Chadi, G. (2005) · International Journal of Neuroscience · doi:10.1080/00207450590521118 · Cited by 29
Park, B., Yang, J.-Y., Yun, N., Choe, K., Jin, B. K., & Oh, Y. J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.005 · Cited by 27
Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice
Liu, J., Wang, M., Gu, P., Ma, Q., Wang, Y.-Y., Geng, Y., Yuan, Z.-Y., Cui, D., Zhang, Z., Ma, L., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.043 · Cited by 25
The Role of PARKIN in Parkinson’s Disease
West, A. B., Dawson, V. L., & Dawson, T. M. (2007) · CRC Press eBooks · doi:10.3109/9781420019223-17 · Cited by 23
Zhang, K. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.671 · Cited by 22
Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1 −/− mice
Nguyen, T. A., Frank-Cannon, T. C., Martinez, T. N., Ruhn, K. A., Marvin, M. A., Casey, B. H., Treviño, I., Hong, J. J., Goldberg, M. S., & Tansey, M. G. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-50 · Cited by 20
Pesticide exposure might be a strong risk factor for Parkinson's disease
Baldereschi, M., Inzitari, M., Vanni, P., Carlo, A. D., & Inzitari, D. (2007) · Annals of Neurology · doi:10.1002/ana.21049 · Cited by 20
Pathophysiologie des sporadischen Morbus Parkinson*
Braak, H., & Tredici, K. D. (2010) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0029-1245179 · Cited by 19
Endogenous Dopamine Is Involved in the Herbicide Paraquat-Induced Dopaminergic Cell Death
Izumi, Y., Ezumi, M., Takada‐Takatori, Y., Akaike, A., & Kume, T. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu054 · Cited by 18
PKC θ activity maintains normal quantal size in chromaffin cells
Staal, R. G. W., Hananiya, A., & Sulzer, D. L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05264.x · Cited by 13
Self-citationBlandini, F. (2013) · Functional Neurology · doi:10.11138/fneur/2013.28.1.005 · Cited by 2
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Self-citationα-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15626-w · Cited by 386
Self-citationWerry, E. L., Bright, F. M., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 279
Sulzer, D., Cassidy, C., Horga, G., Kang, U. J., Fahn, S., Casella, L., Pezzoli, G., Langley, J., Hu, X. P., Zucca, F. A., et al. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0047-3 · Cited by 270
Self-citation
Metadata
- Authors
- Cebrián, C., Loike, J. D., & Sulzer, D.
- Affiliations
- Columbia University Irving Medical Center (US)
- Corresponding author
- Sulzer, David
- Venue
- Current Topics in Behavioral Neurosciences
- Publisher
- Springer Berlin Heidelberg
- Published
- 2014
- Volume
- 22
- Pages
- 237-270
- ISSN
- 1866-3370 (ISSN-L)
- 1866-3389
- OpenAlex
- W2120150976
- Cited by
- 65
- References
- 282
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 7 · 2019: 10 · 2018: 12 · 2017: 10 · 2016: 5 · 2015: 2
- FWCI
- 12.15
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Current topics in behavioral neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (P50NS038370)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, neuroinflammation, neurodegeneration, dopaminergic neurons, substantia nigra, glial activation, inflammatory cytokines, lymphocyte infiltration, cellular stress response, genetic animal models, behavioral symptoms
- MeSH terms
- Animals, Disease Models, Animal, Inflammation, Parkinson Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.